Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
55,920,487
-
Shares change
-
+6,457,026
-
Total reported value, excl. options
-
$146,506,955
-
Value change
-
+$17,809,976
-
Put/Call ratio
-
13%
-
Number of buys
-
48
-
Number of sells
-
38
-
Price
-
$2.62
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q2 2023
As of 30 Jun 2023 Xeris Biopharma Holdings, Inc. - COM (XERS) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,920,487 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, Stonepine Capital Management, LLC, BIOIMPACT CAPITAL LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., Soleus Capital Management, L.P., and MILLENNIUM MANAGEMENT LLC.
This table shows 117 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.